Treatment Outcomes and Prognostic Factors in Mexican Patients with Endometrial Carcinoma with Emphasis on Patients Receiving Radiotherapy after Surgery: An Institutional Perspective

Table 2

Pathology characteristics for Mexican patients with endometrial carcinoma.

Characteristic	Patients	Percentage
Stage FIGO 1988
IA	46	11.2
IB	96	23.3
IC	79	19.2
IIA	44	10.7
IIB	42	10.2
IIIA	47	11.4
IIIB	1	.2
IIIC	55	13.3
IVA	2	.5
Grade
1	165	40
2	115	27.9
3	130	31.6
NOS	2	0.5
Lymphovascular invasion
Yes	57	13.8
No	341	82.8
NOS	14	3.4
Number of nodes
None	168	40.8
1−10	181	43.9
11– 20	51	12.4
21– 30	4	1.0
31– 40	8	1.9
Mean of nodes obtained at surgery	5 (1–40)
Histology
Endometrioid	359	87.1
Papillary serous	21	5.1
Clear cell	10	2.4
Adenosquamous	21	5.1
Glassy cell	1	.2
Size
<3 cm	66	16.0
3 −5.9 cm	100	24.3
>6 cm	77	18.7
NOS	169	41.0
Mean size (cm)	4.78 (0.3–20.5)
Isthmus invasion
Present	76	18.4
Absent	336	81.6
Uterine cervix involvement
Endocervical gland	52	12.6
Stromal	94	22.8
None	266	64.6
Serous Involvement
Present	47	11.4
Absent	365	88.6
Positive peritoneal washing
Present	16	3.9
Absent	352	85.4
NOS	44	10.7
Adnexial involvement
Present	38	9.2
Absent	374	90.8
Number of positive nodes
1	19/412	4.6
2	9/412	2.2
3	6/412	1.5
>3	9/412	2.2
Myometrial invasion
<1/2	138	33.5
>1/2	221	53.6
None	49	11.9
NOS	4	1.0
Para aortic node involvement
Present	17	4.1
Absent	395	95.9
Pelvic node involvement
Present	39	9.5
Absent	373	90.5
Risk categories
Low	99	24.0
Low-intermediate	55	13.3
High intermediate	47	11.4
High	211	51.2

NOS: not otherwise specified.